ABEMACARE: Abemaciclib in combination with endocrine therapy as first line therapy in metastatic breast cancer patients with symptomatic visceral metastases or high tumor burden
Journal title abbreviation:
Cancer Res
Year:
2021
Journal volume:
81 Suppl S
Journal issue:
4
Print-ISSN:
0008-5472
TUM Institution:
45; Klinik und Poliklinik für Frauenheilkunde; Kliniken und Institute